[ad_1]
Breaking news … Good news came from Moderna’s coronavirus vaccine.
As the coronavirus (Covid-19) epidemic, which affects the world, continues at full speed, the good news arrives one after another in vaccination studies. A new statement has emerged regarding the Covid-19 vaccine produced by the American pharmaceutical company Moderna. Head of the vaccination team, Dr. “We think we have an extremely effective vaccine. Now we have the data to prove it.” Dr. Tal Zaks said in a statement challenging the coronavirus epidemic: “We hope to play an important role in eradicating this epidemic,” Tal Zaks said in a statement.
30 THOUSAND PEOPLE PARTICIPATED
30 thousand people participated in the last phase of Moderna’s trials, at this stage, it was announced that the vaccine provided 94.5 percent protection. In a recent study of 196 cases, the vaccine was found to provide 94.1 percent protection. Noting that the vaccine he developed is ready for safety approval, Moderna stated that the vaccine can only transmit the coronavirus with mild flu-like effects, thanks to the vaccine.
APPLICATION FOR APPROVAL HAS BEEN MADE
class = “cf”>
The American pharmaceutical company Moderna has requested its use in the United States and the European Union for the vaccine it has developed (Covid-19).
95 PERCENT EFFECTIVE
After BioNTech, the American biotechnology company Moderna announced that the first data on the vaccine developed against the new type of coronavirus (Kovid-19) revealed that the vaccine was 95.4 percent effective.
